Caloric Restriction Protects against Lactacystin-Induced Degeneration of Dopamine Neurons Independent of the Ghrelin Receptor-Reference-Cited by-同舟云学术

Caloric Restriction Protects against Lactacystin-Induced Degeneration of Dopamine Neurons Independent of the Ghrelin Receptor

Published:2017-03-04 Issue:3 Volume:18 Page:558
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Coppens Jessica,Bentea Eduard,Bayliss Jacqueline,Demuyser Thomas,Walrave Laura,Albertini Giulia,Van Liefferinge Joeri,Deneyer Lauren,Aourz Najat,Van Eeckhaut Ann^ORCID,Portelli Jeanelle,Andrews Zane,Massie Ann,De Bundel Dimitri,Smolders Ilse

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/3/558/pdf

Reference61 articles.

1. Parkinson s disease a review

2. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

3. Parkinson's disease

4. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity

5. High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Caloric Restriction and Intermittent Fasting and Their Combined Exercise on Cognitive Functioning: A Review;Current Nutrition Reports;2024-09-06

2. Ageing, Metabolic Dysfunction, and the Therapeutic Role of Antioxidants;Subcellular Biochemistry;2023

3. The Effects of Dietary Interventions on Brain Aging and Neurological Diseases;Nutrients;2022-11-30

4. Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway;Frontiers in Cellular Neuroscience;2021-12-17

5. Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?;Neuropharmacology;2018-07